Digital Health Medication Adherence Platforms sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Digital Health Medication Adherence Platforms
1.1 - About Digital Health Medication Adherence Platforms sector
Companies in the Digital Health Medication Adherence Platforms category build software and connected solutions that help patients take medications correctly and on time. They combine patient-facing apps, smart dispensing devices, pharmacy integrations and care team dashboards to monitor dosing, prompt refills and escalate risk. The value proposition is higher adherence, fewer avoidable events, improved quality measures and measurable ROI for clinical and pharmacy stakeholders.
Offerings typically include patient reminder apps with dosing schedules and refill prompts, smart pill bottles or connected dispensers that record dosing events, and two-way SMS or IVR outreach. Vendors provide care management dashboards with adherence scoring, population analytics and case workflows, alongside EHR and pharmacy system integration via FHIR or HL7 APIs. Many add medication reconciliation, synchronization programs, predictive risk stratification, telepharmacy counseling, and remote patient monitoring connections to escalate interventions for high-risk cohorts.
Primary customers include health systems and hospitals, retail and specialty pharmacies, and health plans or PBMs. These platforms deliver improved proportion of days covered, higher refill persistence, reduced readmissions and emergency visits, and stronger quality performance such as Star Ratings. Buyers also realize cost savings through targeted outreach, streamlined pharmacy workflows, and better patient engagement across chronic disease populations.
2. Buyers in the Digital Health Medication Adherence Platforms sector
2.1 Top strategic acquirers of Digital Health Medication Adherence Platforms companies
Medisafe
HQ: United States
Website
- Description: Provider of a digital medication engagement platform that combines behavioral science and advanced technology to help patients manage medications, appointments, symptoms, measurements and reports, connect with care teams, and integrate existing pharma support programs. The HIPAA/GDPR-compliant solution offers personalized guidance via iOS and Android apps, supporting over two billion managed doses and driving measurable health-outcome improvements.
- Key Products:
- Medisafe Medication Management App: Mobile iOS and Android app that tracks two billion doses, reminds users, records symptoms and measurements, and guides daily adherence with 4.7-star engagement
- Digital Patient Engagement Platform: Integrates existing pharma patient support programs, delivers scalable personalized guidance and connects patients with care teams to improve health outcomes
- Behavioral Intervention Technology: Uses behavioral science and real-world intelligence to create personalized interventions that keep patients on therapy and drive measurable adherence improvements
- Patient Data & Reporting Suite: Generates appointments, symptom, measurement and trial reports, supplying pharma and care teams with real-world insights for outcome tracking and program optimization.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Digital Health Medication Adherence Platforms sector
M&A buyer group 1: Remote Patient Monitoring
19 companies
View group →
Description: Companies in the Digital Health Remote Patient Monitoring Platforms category provide cloud-based systems that connect at-home patients to clinical teams through connected devices and secure data pipelines. They aggregate physiologic signals, surface actionable insights, and orchestrate care workflows, enabling earlier intervention and reimbursable remote care. Offerings typically span device management, EHR integration, patient engagement, and analytics, helping providers scale virtual care programs with measurable clinical and financial impact.
Huma
HQ: United Kingdom
- Type: N/A
- Employees: ●●●●●
- Description: Provider of AI-driven digital health solutions that include a cloud platform for rapidly building regulated health apps, remote patient monitoring, virtual wards and clinical trial tools, plus AI modules that automate documentation, triage and care workflows to optimise patient outcomes.
- Key Products:
- Huma Cloud Platform: Highly configurable, flexible, disease-agnostic cloud infrastructure offering code-free configuration, multi-device connectivity and hosting of AI/ML models with multiple regulatory clearances for rapid digital health solution deployment
- Remote Patient Monitoring Programmes: Programmes capture real-world health data, enable continuous remote monitoring and self-management, empowering proactive, preventative care while reducing hospital burden
- Companion Apps: Mobile companion applications integrate with the platform to support online or face-to-face consultations, deliver personalised insights and guide patients through their health journeys
- Risk Assessment Tools & AI Algorithms: AI-powered, including generative AI, algorithms analyse patient histories to generate personalised risk assessments, predictive insights and optimise treatment outcomes for clinicians and researchers.
🔒
🔒
🔒
View all 19 companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms in Digital Health Medication Adherence Platforms sector
3.1 - Buyout funds in the Digital Health Medication Adherence Platforms sector
2.2 - Strategic buyer groups for Digital Health Medication Adherence Platforms sector
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Digital Health Medication Adherence Platforms companies
4.2 - Public trading comparable groups for Digital Health Medication Adherence Platforms sector
Valuation benchmark group 1: Population Health Management Software Companies
2 companies
View group →
Description: Companies in this trading comparable group are public software providers delivering population health management and analytics platforms to healthcare providers and payers. They monetize via SaaS subscriptions, per-member-per-month fees, and technology-enabled services that support value-based care, care coordination, and clinical decision support. They are comparable given similar data-driven offerings, customer bases, and recurring revenue models focused on outcomes and cost reduction.
Privia Health
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of technology-driven healthcare solutions, optimizing physician practices, enhancing patient experiences, and rewarding doctors for high-value care through collaboration with medical groups, health plans, and health systems.
- Key Products:
- Practice Management: Tools and services to optimize physician practices
- Patient Portal: Platform for patient engagement and communication
- Value-Based Care: Strategies to improve care quality and reduce costs
- Virtual Care: Telehealth services for remote patient consultations
- Fitness and Nutrition Plans: Personalized health assessments and plans for patients
🔒
🔒
🔒
View all 2 companies in this group
Request Free Trial Now →
🔒
Revenue growth
Median
15.7%
2025E
16.0%
2026E
EBITDA margin
Median
28.2%
2025E
28.6%
2026E
Cash EBITDA margin
Median
27.6%
2025E
28.0%
2026E
EV/Revenue
Median
8.4x
2025E
6.8x
2026E
EV/EBITDA
Median
28.9x
2025E
24.4x
2026E
EV/Cash EBITDA
Median
29.0x
2025E
25.5x
2026E
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →